Injective has successfully secured $40 million in funding to expedite the growth and adoption of Web3 finance. This funding round was supported by Jump Crypto and BH Digital, which is the crypto arm of renowned hedge fund manager Alan Howard.
With this fresh capital infusion, Injective aims to further advance the development of its blockchain infrastructure, specifically optimized for financial applications. The company will also continue to invest in its rapidly expanding ecosystem, solidifying its position as the top choice for Web3 DeFi developers. The funds will be utilized to enhance the utility of the native INJ token, which powers Injective, as well as to create new liquidity avenues for decentralized applications (dApps) built on the Injective platform.
Injective has witnessed unparalleled growth, having processed over 92 million on-chain transactions, outpacing many popular layer one protocols in the market. Thanks to its state-of-the-art infrastructure, Injective can confirm transactions instantly with minimal delays and near-zero fees.
Injective’s dApps have already generated over $7 billion in cumulative trading volume, making it one of the fastest-growing ecosystems in the industry. The recent launch of its multichain CosmWasm smart contracts layer represents a significant step in its evolution, as it now stands as the foremost infrastructure optimized for DeFi applications. Notably, Injective’s smart contract layer can enable automatic execution at every block, making it the first and only blockchain with this capability.
Apart from further development, the new funding will support developers looking to diversify the Injective ecosystem. New applications, including prediction markets, lending protocols, and savings dApps, can leverage Injective’s core modules to expand the ecosystem.
Injective’s increasing appeal within institutional circles on a global scale is also emphasized by this funding. The platform offers solutions to bridge the gap between crypto and traditional finance, a crucial element for the mass adoption of DeFi. Injective provides institutional-grade modules such as a fully on-chain order book, binary options, and derivatives, simplifying the development process for finance-focused projects.
As Injective continues to innovate in the DeFi space, traditional institutions can transition smoothly into the world of Web3-enabled finance. With ongoing upgrades, such as the implementation of negative maker fees for markets launched on Injective, the platform is leading the way in bringing the best financial institutions into the crypto realm.
Injective’s vibrant community of developers and early adopters plays a central role in its mission to create a free and decentralized financial network for all. Since its inception, Injective has been incubated by Binance, and this recent funding further aligns with its goal of empowering its community.
Eric Chen, co-founder and CEO of Injective Labs, expressed excitement about collaborating with partners like Jump Crypto, emphasizing the positive impact on the broader Injective ecosystem. He sees the partnership with Jump as a significant force in the crypto landscape, aimed at expanding Injective’s network and increasing adoption within its ecosystem.
About Injective: Injective is a custom interoperable layer one protocol designed for creating powerful exchange, DeFi, derivatives, and Web3 applications. Built using the Cosmos SDK, Injective achieves instant transaction finality while maintaining rapid transaction speeds. INJ is the native deflationary scarce asset that fuels the Injective Protocol and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by Pantera Capital.
Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook | LinkedIn | Reddit | Instagram | Weibo | Orbit Newsletter
